Zhong LeQi, Zhong JiuDi, Tan ZiHui, Wei YiTong, Su XiaoDong, Wen ZheSheng, Rong TieHua, Hu Yi, Luo KongJia
Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Department of Thoracic Suegry, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China.
Front Oncol. 2021 May 17;11:657955. doi: 10.3389/fonc.2021.657955. eCollection 2021.
To explore the comprehensive role of systemic endoscopic intervention in healing esophageal anastomotic leak.
In total, 3919 consecutive patients with esophageal cancer who underwent esophagectomy and immediate esophageal reconstruction were screened. In total, 203 patients (5.10%) diagnosed with anastomotic leakage were included. The participants were divided into three groups according to differences in diagnosis and treatment procedures. Ninety-four patients received conventional management, 87 patients received endoscopic diagnosis only, and the remaining 22 patients received systematic endoscopic intervention. The primary endpoint was overall healing of the leak after oncologic esophageal surgery. The secondary endpoints were the time from surgery to recovery and the occurrence of adverse events.
173 (85.2%; 95% CI, 80.3-90.1%) of the 203 patients were successfully healed, with a mean healing time of 66.04 ± 3.59 days (median: 51 days; range: 13-368 days), and the overall healing rates differed significantly among the three groups according to the stratified log-rank test (P<0.001). The median healing time of leakage was 37 days (95% CI: 33.32-40.68 days) in the endoscopic intervention group, 51 days (95% CI: 44.86-57.14 days) in the endoscopic diagnostic group, and 67 days (95% CI: 56.27-77.73 days) in the conventional group. The overall survival rate was 78.7% (95% CI: 70.3 to 87.2%) in the conventional management group, 89.7% (95% CI: 83.1 to 96.2%) in the endoscopic diagnostic group and 95.5% (95% CI: 86.0 to 100%) in the systematic endoscopic intervention group. Landmark analysis indicated that the speed of wound healing in the endoscopic intervention group was 2-4 times faster at any period than that in the conservative group. There were 20 (21.28%) deaths among the 94 patients in the conventional group, 9 (10.34%) deaths among the 87 patients in the endoscopic diagnostic group and 1 (4.55%) death among the 22 patients in the endoscopic intervention group; this difference was statistically significant (Fisher exact test, P < 0.05).
Tailored endoscopic treatment for postoperative esophageal anastomotic leakage based on endoscopic diagnosis is feasible and effective. Systematic endoscopic intervention shortened the treatment period and reduced mortality and should therefore be considered in the management of this disease.
探讨系统性内镜干预在食管吻合口漏愈合中的综合作用。
对3919例连续接受食管癌切除术并立即进行食管重建的患者进行筛查。共纳入203例(5.10%)诊断为吻合口漏的患者。根据诊断和治疗程序的差异将参与者分为三组。94例患者接受传统治疗,87例患者仅接受内镜诊断,其余22例患者接受系统性内镜干预。主要终点是肿瘤性食管手术后漏口的总体愈合情况。次要终点是从手术到恢复的时间以及不良事件的发生情况。
203例患者中有173例(85.2%;95%可信区间,80.3 - 90.1%)成功愈合,平均愈合时间为66.04±3.59天(中位数:51天;范围:13 - 368天),根据分层对数秩检验,三组的总体愈合率差异有统计学意义(P<0.001)。内镜干预组漏口的中位愈合时间为37天(95%可信区间:33.32 - 40.68天),内镜诊断组为51天(95%可信区间:44.86 - 57.14天),传统组为67天(95%可信区间:56.27 - 77.73天)。传统治疗组的总生存率为78.7%(95%可信区间:70.3至87.2%),内镜诊断组为89.7%(95%可信区间:83.1至96.2%),系统性内镜干预组为95.5%(95%可信区间:86.0至100%)。地标分析表明,内镜干预组在任何时期的伤口愈合速度都比保守组快2 - 4倍。传统组94例患者中有20例(21.28%)死亡,内镜诊断组87例患者中有9例(10.34%)死亡,内镜干预组22例患者中有1例(4.55%)死亡;这种差异有统计学意义(Fisher精确检验,P<0.05)。
基于内镜诊断的术后食管吻合口漏的个体化内镜治疗是可行且有效的。系统性内镜干预缩短了治疗周期并降低了死亡率,因此在该病的治疗中应予以考虑。